This week's Fierce Biotech is brought to you by Avantor.

Novel Cell Lysis Solution: Scaling up the harvest process while preserving what matters

Gene therapy has the potential to transform healthcare, but manufacturing challenges often stand in the way of progress. Chemical lysis is a preferred method, yet current solutions have significant drawbacks:

• Environmental concerns: Industry-preferred reagents face regulatory scrutiny.
• Inefficiency: High viscosity, foaming, and damage to viral vectors hinder success.
• Complex handling: Storage and shipping requirements complicate processes.

This whitepaper introduces a novel biodegradable cell lysis solution that addresses these issues and delivers:

• Improved viral vector release efficiency at various cell densities and temperatures.
• Reduced viscosity and foaming for easier processing.
• Room-temperature storage and shipping for simplified logistics.

Learn how this ready-to-use solution can enhance scalability and protect what matters most.Let’s unlock the full potential of gene therapy manufacturing, together.